Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,236.30
+70.10 (6.01%)
Jun 3, 2026, 11:01 AM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 122 billion as of June 2, 2026. Its market cap has decreased by -22.82% in one year.
Market Cap
122.00B
Enterprise Value
117.85B
Revenue
10.55B
Ranking
n/a
PE Ratio
47.06
Stock Price
1,236.30
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 122.00B, an increase of 23.70%. That is a compound annual growth rate of 7.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 111.03B | -21.13% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 693.71B |
| Anthem Biosciences | 426.80B |
| OneSource Specialty Pharma | 209.18B |
| Supriya Lifescience | 77.96B |
| Blue Jet Healthcare | 77.95B |
| Zota Health Care | 38.97B |
| Dishman Carbogen Amcis | 30.53B |
| Panacea Biotec | 25.29B |